Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Psoriasis
|
705 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.020 | 2 | 2017 | 2019 | ||||||
Autoimmune liver disease
|
3 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.010 | 1 | 2018 | 2018 | ||||||
Kidney Failure, Acute
|
32 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.010 | 1 | 2019 | 2019 | ||||||
Malignant Neoplasms
|
1641 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.010 | 1 | 2015 | 2015 | ||||||
Primary malignant neoplasm
|
1374 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.010 | 1 | 2015 | 2015 | ||||||
Breast Carcinoma
|
2793 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.030 | 0.333 | 3 | 2012 | 2014 | |||||
Malignant neoplasm of breast
|
3417 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.030 | 0.333 | 3 | 2012 | 2014 | |||||
Multiple Sclerosis
|
1022 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.020 | 0.500 | 2 | 2017 | 2019 | |||||
Acute pancreatitis
|
51 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.030 | 0.667 | 3 | 2013 | 2017 | |||||
Lupus Erythematosus, Systemic
|
1172 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.030 | 0.667 | 3 | 2018 | 2019 | |||||
Malignant neoplasm of prostate
|
1082 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.030 | 0.667 | 3 | 2011 | 2017 | |||||
Prostate carcinoma
|
1168 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.030 | 0.667 | 3 | 2011 | 2017 | |||||
Colorectal Carcinoma
|
1962 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.040 | 0.750 | 4 | 2009 | 2014 | |||||
Tuberculosis
|
328 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.040 | 0.750 | 4 | 2015 | 2020 | |||||
Ischemic stroke
|
704 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.050 | 0.800 | 5 | 2010 | 2020 | |||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.050 | 1.000 | 5 | 2010 | 2019 | |||||
Asthma
|
1536 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.040 | 1.000 | 4 | 2014 | 2019 | |||||
Diabetic Retinopathy
|
213 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.040 | 1.000 | 4 | 2017 | 2019 | |||||
Hepatitis C
|
347 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.040 | 1.000 | 4 | 2013 | 2018 | |||||
Alzheimer's Disease
|
1843 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.030 | 1.000 | 3 | 2007 | 2016 | |||||
Bronchiolitis
|
32 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.030 | 1.000 | 3 | 2017 | 2019 | |||||
Coronary Artery Disease
|
1577 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.030 | 1.000 | 3 | 2012 | 2016 | |||||
Inflammatory Bowel Diseases
|
605 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.030 | 1.000 | 3 | 2014 | 2016 | |||||
Nasopharyngeal carcinoma
|
320 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.030 | 1.000 | 3 | 2013 | 2017 | |||||
Adult Lymphoma
|
66 | 0.507 | 0.800 | 1 | 206773552 | intron variant | T/C | snv | 0.41 | 0.020 | 1.000 | 2 | 2008 | 2010 |